Get ready for the climb. Here's what history says about stock-market returns during Fed rate-hike cycles.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 75 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 97%

Singapore News News

Singapore Singapore Latest News,Singapore Singapore Headlines

As it turns out, during so-called Federal Reserve interest rate-hike cycles, which we seem set to enter as early as March, the U.S. stock market tends to...

Bond yields are rising again so far in 2022. The U.S. stock market seems vulnerable to a bona fide correction. But what can you really tell from a mere two weeks into a new year? Not much and quite a lot.

The only real question is how many interest-rate increases will the Federal Open Market Committee dole out in 2022. JPMorgan Chase & Co. JPM, -6.15% CEO Jamie Dimon intimated that seven might be the number to beat, with market-based projections pointing to the potential for three increases to the federal funds rate in the coming months.

The 2-year note TMUBMUSD02Y, 0.960%, which tends to be more sensitive to the Fed’s interest rate moves, is knocking on the door of 1%, up 24 basis points so far this year, FactSet data show.As it turns out, during so-called rate-hike cycles, which we seem set to enter into as early as March, the market tends to perform strongly, not poorly.

To be sure, it is harder to see the market producing outperformance during a period in which the economy experiences 1970s-style inflation. Right now, it feels unlikely that bullish investors will get a whiff of double-digit returns based on the way stocks are shaping up so far in 2022. The Dow is down 1.2%, the S&P 500 is off 2.2%, while the Nasdaq Composite is down a whopping 4.8% thus far in January.

Meanwhile, value themes are making a more pronounced comeback, eking out a 0.1% weekly gain last week, as measured by the iShares S&P 500 Value ETF IVE, -0.14%, but month to date the return is 1.2%. What’s really not working? Biotech stocks are getting shellacked, with the iShares Biotechnology ETF IBB, +0.65% down 1.1% on the week and 9% on the month so far.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to her Alexander__Jeni Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success

Singapore Singapore Latest News, Singapore Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

European Stocks Set to Fall as Hawkish Fed Remarks Dent Global SentimentEuropean stocks are set to pull back on Friday, tracking global momentum following a fresh round of hawkish comments from Federal Reserve officials.
Source: NBCDFW - 🏆 288. / 63 Read more »